Earlier this month, Waters revised downwards its sales and earnings outlook for the fourth quarter. While the company had earlier predicted sales would grow 4 percent, before currency effects, it now expects sales to decline by 2 percent. Quarterly earnings per share, originally estimated at $0.46, will now likely be $0.38-$0.40.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.